Trialize AG

About associationChaptersDigital & health technologies

Digital & health technologies chapter

Advancing therapeutic development through digital technologies, data and AI

  • AI & machine learning
  • Drug discovery
  • Clinical trials
  • Data infrastructure

Starting position

Digital technologies are transforming therapeutic development

Digital and computational technologies are opening new possibilities across the discovery, development and delivery of therapeutics.

Digital and computational approaches turn complex data into actionable insights and support better-informed decisions in target identification, drug property prediction, personalized treatments, clinical trial optimization and drug repurposing.

Secure, interoperable data infrastructure enables trusted, scalable innovation. Together, these technologies and data ecosystems advance therapeutic development, precision diagnostics and clinically relevant digital solutions.

Vision

Positioning Switzerland at the forefront of digitally enabled biotechnology

The chapter aims to strengthen Switzerland’s position as a leading hub for digital innovation in biotechnology, where digital technologies, data and AI accelerate therapeutic development, inform clinical decisions and contribute to better patient outcomes. By connecting technology developers, biotech companies, researchers and clinical experts, the chapter fosters knowledge exchange and collaboration to drive innovation and the adoption of digital solutions.

Mission

Connecting digital innovation with therapeutic impact

The chapter connects companies, researchers and industry partners across the digital and life sciences communities to foster collaboration, knowledge exchange and commercially relevant innovation. It promotes Swiss expertise and the adoption of digital technologies. Its focus spans target identification and validation, drug property prediction and optimization, precision medicine, clinical trial optimization, computational drug repurposing, and digital companion diagnostics and therapeutics. It also promotes trusted data infrastructure and privacy-preserving collaboration to support the development and adoption of these technologies.

Fostering networking

Connecting digital technology and life sciences communities through national and international partnerships, complemented by joint events that foster knowledge exchange and collaboration.

Attracting talent & capital

Supporting commercially relevant innovation, sharing market intelligence and connecting digital technologies companies with investors, potential customers and talent.

Promoting the segment

Serving as a trusted source of information for external stakeholders, while raising the profile of Swiss digital and health technologies and showcasing their contributions to therapeutic innovation through success stories.

Shaping framework

Helping shape favorable and competitive framework conditions for digital innovation in biotechnology, including trusted data use, interoperability and the responsible adoption of AI.

Chapter partners

Discover the digital & health technologies community

The digital & health technologies chapter is a joint activity of the Swiss Biotech Association and DayOne.

Digital & health technologies in action

Explore pioneering companies

Discover selected companies from the chapter and explore how their technologies are advancing therapeutic discovery, development and delivery, from computational drug discovery to precision diagnostics and clinically relevant digital solutions.

Delegates walking the exhibition floor at the Swiss Biotech Day
Swiss Biotech Day · April 26–27, 2027 · Congress Center Basel

Showcasing digital & health technologies on a global stage

Engage at the Swiss Biotech Day

The Swiss Biotech Day, our flagship annual event and one of the world’s premier biotechnology conferences, offers the digital & health technologies chapter a prominent platform to showcase its innovations, expertise, and industry impact.

Want to showcase your innovations, share your expertise, or expand your network? Companies and experts from the digital & health technologies chapter are invited to express their interest early in sponsorship opportunities, pitching slots, or panel discussions to help shape the chapter program and connect with an international audience.

The 2026 pitching competition winners were Lemna Bio, Precise Health and ALP Bio.

Highlights from the Swiss Biotech Day 2026

Digital & health technologies on the global stage

Explore how expert discussions and startup pitches highlighted the role of digital technologies, data and AI in precision oncology and therapeutic development at the Swiss Biotech Day.

Panel discussion: Liquid biopsy at a tipping point in precision oncology. How AI-powered analytics and collaboration are advancing liquid biopsy and precision oncology.

Pitching session: AI-driven breakthroughs from target to therapy. Startups showcased AI, digital twins and engineered biologics in drug development.

Get involved

Advance digital innovation in biotechnology

Companies, researchers and experts working across digital technologies and life sciences are welcome to participate, whether or not they are members of the Swiss Biotech Association.

Exchange expertise, showcase innovations and connect digital technologies with therapeutic development. The chapter’s main stage is the Swiss Biotech Day. Contact the chapter head to:

  • Pitch your company or technology and showcase your innovations
  • Share your expertise in a panel discussion
  • Raise your visibility as a sponsor